应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
OTLK Outlook Therapeutics, Inc.
交易中 04-23 15:26:23 EDT
8.29
+0.20
+2.47%
最高
8.44
最低
8.15
成交量
12.70万
今开
8.21
昨收
8.09
日振幅
3.58%
总市值
1.85亿
流通市值
1.32亿
总股本
2,230万
成交额
105.04万
换手率
0.80%
流通股本
1,597万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Outlook Therapeutics, Inc.盘中异动 股价大涨5.14%
自选股智能写手 · 04-17
Outlook Therapeutics, Inc.盘中异动 股价大涨5.14%
Outlook Therapeutics, Inc.盘中异动 早盘快速下跌5.51%报8.75美元
自选股智能写手 · 04-10
Outlook Therapeutics, Inc.盘中异动 早盘快速下跌5.51%报8.75美元
Outlook Therapeutics, Inc.盘中异动 急速上涨5.26%报10.21美元
自选股智能写手 · 04-03
Outlook Therapeutics, Inc.盘中异动 急速上涨5.26%报10.21美元
Outlook Therapeutics, Inc.盘中异动 早盘股价大涨5.75%报7.17美元
自选股智能写手 · 03-21
Outlook Therapeutics, Inc.盘中异动 早盘股价大涨5.75%报7.17美元
Outlook Therapeutics, Inc.盘中异动 股价大跌5.46%报7.79美元
自选股智能写手 · 03-18
Outlook Therapeutics, Inc.盘中异动 股价大跌5.46%报7.79美元
Outlook Therapeutics, Inc.盘中异动 早盘急速上涨5.58%报6.05美元
自选股智能写手 · 03-15
Outlook Therapeutics, Inc.盘中异动 早盘急速上涨5.58%报6.05美元
Outlook Therapeutics, Inc.盘中异动 早盘股价大跌5.45%报6.11美元
自选股智能写手 · 03-14
Outlook Therapeutics, Inc.盘中异动 早盘股价大跌5.45%报6.11美元
加载更多
公司概况
公司名称：
Outlook Therapeutics, Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Outlook Therapeutics, Inc.于2010年1月5日在新泽西州注册成立。该公司是一家临床晚期生物制药公司，致力于开发首个经美国食品和药物管理局（FDA）批准用于视网膜适应症的贝伐单抗眼科制剂。他们直接或通过战略合作伙伴推出贝伐单抗，作为美国、英国、欧洲、日本等市场首个也是唯一批准的贝伐单抗，用于治疗湿性老年性黄斑变性、湿性AMD、糖尿病性黄斑水肿（DME）和视网膜分支静脉阻塞，他们正在就ONS-5010的许可和共同开发权进行积极的后期讨论。
发行价格：
--
{"stockData":{"symbol":"OTLK","market":"US","secType":"STK","nameCN":"Outlook Therapeutics, Inc.","latestPrice":8.29,"timestamp":1713900343758,"preClose":8.09,"halted":0,"volume":127023,"delay":0,"floatShares":15969400,"shares":22298542,"eps":-3.98612,"marketStatus":"交易中","marketStatusCode":2,"change":0.2,"latestTime":"04-23 15:26:23 EDT","open":8.21,"high":8.44,"low":8.15,"amount":1050371.351289,"amplitude":0.035847,"askPrice":8.33,"askSize":100,"bidPrice":8.29,"bidSize":7866,"shortable":3,"etf":0,"ttmEps":-3.98612,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1713902400000},"adr":0,"adjPreClose":8.09,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.37,"preClose":8.09,"latestTime":"09:17 EDT","volume":40,"amount":333.6,"timestamp":1713878240373},"postHourTrading":{"tag":"盘后","latestPrice":8.13,"preClose":8.09,"latestTime":"19:35 EDT","volume":28116,"amount":227503.84,"timestamp":1713828941912},"volumeRatio":0.545406},"requestUrl":"/m/hq/s/OTLK","defaultTab":"news","newsList":[{"id":"2428340951","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428340951","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428340951?lang=zh_cn&edition=full","pubTime":"2024-04-17 23:03","pubTimestamp":1713366235,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日23时03分，Outlook Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。截至发稿，该股报9.20美元/股，成交量7.3888万股，换手率0.33%，振幅4.33%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vanda Pharmaceuticals Inc.、Viracta Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃，换手率分别为136.65%、37.64%、37.00%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Dare Bioscience, Inc.，振幅分别为80.94%、48.51%、41.02%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723035579214569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723035579214569&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426977804","title":"Outlook Therapeutics, Inc.盘中异动 早盘快速下跌5.51%报8.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426977804","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426977804?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:55","pubTimestamp":1712757327,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时55分，Outlook Therapeutics, Inc.股票出现波动，股价大幅下挫5.51%。截至发稿，该股报8.75美元/股，成交量5.4482万股，换手率0.25%，振幅2.81%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1382.44%、71.17%、28.79%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Calidi Biotherapeutics, Inc.、Silo Pharma, Inc.，振幅分别为62.83%、31.96%、24.26%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021552787e7f4e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021552787e7f4e8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424846776","title":"Outlook Therapeutics, Inc.盘中异动 急速上涨5.26%报10.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424846776","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424846776?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:36","pubTimestamp":1712151395,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时36分，Outlook Therapeutics, Inc.股票出现异动，股价大幅上涨5.26%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Kintara Therapeutics, Inc.、方舟生物医药、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Addex Therapeutics Limited较为活跃，换手率分别为268.17%、90.14%、16.54%，振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、Tracon Pharmaceuticals, Inc.，振幅分别为29.88%、23.39%、22.04%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032136357a50f897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032136357a50f897&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421045043","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大涨5.75%报7.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421045043","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421045043?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:32","pubTimestamp":1711027945,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时32分，Outlook Therapeutics, Inc.股票出现异动，股价大幅上涨5.75%。截至发稿，该股报7.17美元/股，成交量5250股，换手率0.02%，振幅2.06%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213226861e0172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213226861e0172&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472306","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌5.46%报7.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472306","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420472306?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:33","pubTimestamp":1710768784,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时33分，Outlook Therapeutics, Inc.股票出现波动，股价快速下挫5.46%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm Plc较为活跃，换手率分别为59.19%、12.05%、6.97%，振幅较大的相关个股有Elicio Therapeutics, Inc.、2Seventy Bio, Inc.、Molecular Templates, Inc.，振幅分别为12.93%、12.72%、12.55%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182133047a4d6f2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182133047a4d6f2a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419974484","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速上涨5.58%报6.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419974484","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419974484?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:43","pubTimestamp":1710510184,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时43分，Outlook Therapeutics, Inc.股票出现波动，股价急速拉升5.58%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至21时43分，《Outlook TherapeuticsEvanson Jeff增持6.25万股普通股股份，价值约2.62万美元》资讯为影响Outlook Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315214304861deac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315214304861deac6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419602544","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大跌5.45%报6.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419602544","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419602544?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:35","pubTimestamp":1710423322,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时35分，Outlook Therapeutics, Inc.股票出现异动，股价大幅跳水5.45%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至21时35分，《Outlook TherapeuticsEvanson Jeff增持6.25万股普通股股份，价值约2.62万美元》资讯为影响Outlook Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142135227a4cb5ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142135227a4cb5ea&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.outlooktherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0615},{"period":"1month","weight":-0.0626},{"period":"3month","weight":-0.0886},{"period":"6month","weight":-0.2368},{"period":"1year","weight":-0.6543},{"period":"ytd","weight":0.0266}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0412},{"period":"3month","weight":0.0306},{"period":"6month","weight":0.1968},{"period":"1year","weight":0.2123},{"period":"ytd","weight":0.0514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Outlook Therapeutics, Inc.于2010年1月5日在新泽西州注册成立。该公司是一家临床晚期生物制药公司，致力于开发首个经美国食品和药物管理局（FDA）批准用于视网膜适应症的贝伐单抗眼科制剂。他们直接或通过战略合作伙伴推出贝伐单抗，作为美国、英国、欧洲、日本等市场首个也是唯一批准的贝伐单抗，用于治疗湿性老年性黄斑变性、湿性AMD、糖尿病性黄斑水肿（DME）和视网膜分支静脉阻塞，他们正在就ONS-5010的许可和共同开发权进行积极的后期讨论。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.120556},{"month":2,"riseRate":0.5,"avgChangeRate":0.214631},{"month":3,"riseRate":0.375,"avgChangeRate":-0.032392},{"month":4,"riseRate":0.375,"avgChangeRate":-0.159772},{"month":5,"riseRate":0.714286,"avgChangeRate":0.203291},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.047991},{"month":7,"riseRate":0.5,"avgChangeRate":0.018263},{"month":8,"riseRate":0.375,"avgChangeRate":-0.146061},{"month":9,"riseRate":0.5,"avgChangeRate":0.064501},{"month":10,"riseRate":0.375,"avgChangeRate":0.187824},{"month":11,"riseRate":0.125,"avgChangeRate":-0.10027},{"month":12,"riseRate":0.375,"avgChangeRate":-0.109516}],"exchange":"NASDAQ","name":"Outlook Therapeutics, Inc.","nameEN":"Outlook Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Outlook Therapeutics, Inc.,OTLK,Outlook Therapeutics, Inc.股票,Outlook Therapeutics, Inc.股票老虎,Outlook Therapeutics, Inc.股票老虎国际,Outlook Therapeutics, Inc.行情,Outlook Therapeutics, Inc.股票行情,Outlook Therapeutics, Inc.股价,Outlook Therapeutics, Inc.股市,Outlook Therapeutics, Inc.股票价格,Outlook Therapeutics, Inc.股票交易,Outlook Therapeutics, Inc.股票购买,Outlook Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}